Alyeska Investment Group »

Evommune shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 726k 22.99

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Micron Technology (MU)
Robinhood Mkts Com Cl A (HOOD)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Gpgi Com Cl A (GPGI)
Amphenol Corp Cl A (APH)
Cisco Systems (CSCO)
Hilton Worldwide Holdings (HLT)
Burlington Stores (BURL)
Merck & Co (MRK)
Zebra Technologies Corporati Cl A (ZBRA)

View all positions for Alyeska Investment Group

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune